Clinical efficacy and safety of Guipi decoction combined with escitalopram oxalate tablets in patients with depression

被引:2
|
作者
Yu, Jia [1 ]
Xu, Feng-Quan [2 ,3 ]
机构
[1] Beijing Changping Hosp Tradit & Western Med, Psychiat Dept, Beijing 102206, Peoples R China
[2] Chinese Acad Tradit Chinese Med, Guanganmen Hosp, Dept Psychosomat Med, Beijing 100053, Peoples R China
[3] Chinese Acad Tradit Chinese Med, Guanganmen Hosp, Dept Psychosomat Med, 5 Beixiange, Beijing 100053, Peoples R China
关键词
Jiajian Guipi decoction; Escitalopram oxalate tablets; Depressive disorder; Sleep quality; Traditional Chinese medicine syndromes; PREVALENCE; DISORDERS; THERAPY;
D O I
10.12998/wjcc.v11.i29.7017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDDepression is a widespread mental health condition that requires effective treatment. In the treatment of depression, traditional Chinese medicine (TCM) offers obvious advantages, fewer adverse reactions, and a lower recurrence rate. AIMTo evaluate the clinical benefits of Guipi decoction combined with escitalopram oxalate tablets for individuals with depression. METHODSIn total, 80 patients diagnosed as having depression were enrolled in the study and divided into either an experimental group or a control group. All of the patients were orally administered escitalopram oxalate tablets. Additionally, the experimental group received Jiajian Guipi decoction and reduced Governor vessel fumigation over 4 wk. TCM syndrome scores, Hamilton depression rating scale (HAM-D) scores, self-rating depression scale (SDS) scores, and Pittsburgh sleep quality index scores were measured for the two groups and compared before and after the treatment. The two groups were monitored for any adverse reactions. RESULTSAfter 4 wk of treatment, both groups exhibited a significant reduction in TCM syndrome scores compared with their pre-treatment scores (P < 0.05). However, the experimental group exhibited significantly lower TCM syndrome scores than the control group (P < 0.05). Similarly, the post-treatment SDS and HAM-D-24 scores were significantly lower in both groups than the pre-treatment scores (P < 0.05), with the experimental group exhibiting lower scores than the control group (P < 0.05). The total treatment efficiency was significantly better in the experimental group (97.14%) than in the control group (77.78%) (P < 0.05). Furthermore, after 4 wk of treatment, the Pittsburgh sleep quality index scores for both groups were significantly lower than those before the treatment (P < 0.05), with the experimental group exhibiting lower scores than the control group (P < 0.05). The incidence of adverse reactions was significantly lower in the experimental group than in the control group (P < 0.05). CONCLUSIONThe combination of Guipi decoction and escitalopram oxalate tablets was found to be an effective and safe treatment for depression. This combination could reduce TCM syndrome scores, improve depressive symptoms, and enhance sleep quality.
引用
收藏
页码:7017 / 7025
页数:9
相关论文
共 50 条
  • [21] Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
    Yoshimura, Reiji
    Okamoto, Naomichi
    Igata, Ryohei
    Ikenouchi, Atsuko
    ALPHA PSYCHIATRY, 2022, 23 (01): : 40 - 41
  • [22] Efficacy and safety of escitalopram in patients with first episode of MDD
    Kadavala, Bhavin
    Patel, Mayur
    Patel, Vishal
    Tiwari, Deepak
    Patel, Dhruv
    Raja, Hitarth
    Chanpa, Nirav
    INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (09) : S601 - S601
  • [23] Efficacy and safety of Guipi Decoction in the treatment of chronic heart failure: A systematic review and meta-analysis of randomized controlled trials
    Rong, Yuanhang
    Wu, Di
    Li, Ming
    Teng, Jing
    MEDICINE, 2023, 102 (09) : E33181
  • [24] Efficacy and tolerability of Escitalopram in patients with mild, moderate and severe depression
    Stamouli, S.
    Yfantis, A.
    Zouganelli, A.
    Lampousis, E.
    Giailoglou, D.
    Parashos, I.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 320 - 320
  • [25] Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache
    Yao Wang
    Xiaoyu Yang
    Xiaojun Ji
    Min Liu
    Chang Zhou
    Psychopharmacology, 2023, 240 : 2061 - 2070
  • [26] The Efficacy of Escitalopram Combined with Olanzapine in Depression: A Systematic Review and Meta-analysis
    孙璇
    王哲
    苗德田
    王东军
    关媛媛
    田之魁
    田春颖
    朱青青
    周宗慧
    步怀恩
    王泓午
    World Journal of Integrated Traditional and Western Medicine, 2021, 7 (05) : 24 - 35
  • [27] Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache
    Wang, Yao
    Yang, Xiaoyu
    Ji, Xiaojun
    Liu, Min
    Zhou, Chang
    PSYCHOPHARMACOLOGY, 2023, 240 (10) : 2061 - 2070
  • [28] Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function
    Mi, Kun
    Guo, Qiang
    Xu, Bao-yan
    Wang, Man
    Bi, Hao
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (04) : 1054 - 1057
  • [29] The comparison of efficacy of Escitalopram and Bupropion in treatment of depression symptoms in patients with heart failure: randomized clinical trial
    Hamzehpour, Romina
    Hamidia, Angela
    Ramezani, Azadeh
    Abrootan, Saeed
    Shirafkan, Hoda
    Moallem, Hirbod Hadizadeh
    Tavakoli, Negin
    Ziaie, Naghmeh
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (11): : 6546 - 6554
  • [30] Efficacy and Safety of Montelukast Sodium Tablets Combined with Budesonide Suspension in the Treatment of Patients with Bronchial Asthma
    Liu, Deyun
    Fei, Dawei
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2024, 58 (03) : 389 - 393